Luigi Mangione’s legal team has withdrawn plans to introduce psychiatric evidence in his upcoming state murder trial, according to a court filing submitted on Thursday. The decision marks a reversal from the previous day, when Mangione’s attorneys had indicated they intended to pursue a psychiatric defense strategy for the case involving the fatal shooting of UnitedHealthcare CEO Brian Thompson.
In the Thursday filing, Mangione’s lawyers stated that they would not file psychiatric evidence in the 28-year-old's state murder case. This move came just one day after his legal team announced plans to pursue a psychiatric defense. The withdrawal suggests a strategic shift in how the defense intends to present its case regarding Mangione's mental state at the time of the alleged crime.
Reuters reported on June 18 that Mangione, who is accused of gunning down a health insurance executive on a Manhattan sidewalk, is for now withdrawing plans to introduce evidence at trial that he was suffering from mental health issues. The report highlights the timing of this withdrawal, noting it occurs shortly after initial indications that such evidence would be part of the defense strategy.
The case centers on the fatal shooting of Brian Thompson, the CEO of UnitedHealthcare. Mangione is accused of killing Thompson on a sidewalk in Manhattan. As the trial approaches, the legal team's decision to withdraw the psychiatric defense plan removes a potential avenue for arguing diminished capacity or insanity based on mental health conditions. This development leaves the defense with other options or requires them to rely on different arguments regarding the circumstances of the shooting.
No right-leaning sources reported on this story.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy